Loa loa Microfilarial Periodicity in Ivermectin-Treated Patients: Comparison Between Those Developing and Those Free of Serious Adverse Events

被引:27
作者
Kamgno, Joseph [1 ]
Pion, Sebastien D. [2 ]
Mackenzie, Charles D. [3 ]
Thylefors, Bjoern [4 ]
Boussinesq, Michel [2 ]
机构
[1] Univ Yaounde I, Filariasis Res Ctr, Yaounde, Cameroon
[2] Inst Rech Dev, UMR 145, F-34394 Montpellier 5, France
[3] Michigan State Univ, Filarial Dis Unit, E Lansing, MI 48824 USA
[4] Mectizan Donat Program, Decatur, GA 30030 USA
关键词
ONCHOCERCA-VOLVULUS MICROFILARIAE; WUCHERERIA-BANCROFTI; DIROFILARIA-IMMITIS; DIETHYLCARBAMAZINE; ENCEPHALITIS; INFECTION; EFFICACY; LOIASIS; TRIAL; AREA;
D O I
10.4269/ajtmh.2009.09-0356
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The main risk factor of post-ivermectin serious adverse events (SAEs) is the presence of a high Loa loa microfilaremia. However, the majority of patients with such high loads do not develop SAEs, suggesting that co-factors may be involved. An infection with simian Loa parasites, whose microfilariae show a nocturnal periodicity, might be such a co-factor. The periodicity of Loa microfilariae was compared, using cosinor methodology, in 4 patients who had developed a post-ivermectin neurologic SAE, 4 patients who had experienced a non-neurologic SAE, and 14 control individuals. The periodicity was similar in all three groups, with a peak of microfilaremia occurring between 12:30 and 2:00 PM. The results of this study, which for the first time characterizes the periodicity of Loa microfilariae mathematically, suggest that post-ivermectin SAEs are not related to an infection with a Loa simian strain.
引用
收藏
页码:1056 / 1061
页数:6
相关论文
共 54 条
  • [1] Microfilarial periodicity of Wuchereria bancrofti in Vanuatu
    Abe, M
    Yaviong, J
    Taleo, G
    Ichimori, K
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2003, 97 (05) : 498 - 500
  • [2] AIKAT TK, 1977, INDIAN J MED RES, V65, P58
  • [3] THE CHEMOTHERAPY OF ONCHOCERCIASIS .10. AN ASSESSMENT OF 4 SINGLE DOSE TREATMENT REGIMES OF MK-933 (IVERMECTIN) IN HUMAN ONCHOCERCIASIS
    AWADZI, K
    DADZIE, KY
    SHULZKEY, H
    HADDOCK, DRW
    GILLES, HM
    AZIZ, MA
    [J]. ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1985, 79 (01): : 63 - 78
  • [4] Awadzi K, 1997, ANN TROP MED PARASIT, V91, P281, DOI 10.1080/00034989761139
  • [5] BASSET D, 1989, PATHOL BIOL, V37, P668
  • [6] Circadian pattern of cercarial emergence in Schistosoma mansoni (Platyhelminthes: Digenea) from isolated Biomphalaria glabrata
    Bogea, T
    Favre, TC
    Rotenberg, L
    Silva, HS
    Pieri, OS
    [J]. CHRONOBIOLOGY INTERNATIONAL, 1996, 13 (02) : 93 - 101
  • [7] Three probable cases of Loa Loa encephalopathy following ivermectin treatment for onchocerciasis
    Boussinesq, M
    Gardon, J
    Gardon-Wendel, N
    Kamgno, J
    Ngoumou, P
    Chippaux, JP
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1998, 58 (04) : 461 - 469
  • [8] Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon
    Boussinesq, M
    Gardon, J
    Kamgno, J
    Pion, SDS
    Gardon-Wendel, N
    Chippaux, JP
    [J]. ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2001, 95 (05): : 495 - 507
  • [9] 5 CASES OF ENCEPHALITIS DURING TREATMENT OF LOIASIS WITH DIETHYLCARBAMAZINE
    CARME, B
    BOULESTEIX, J
    BOUTES, H
    PURUEHNCE, MF
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1991, 44 (06) : 684 - 690
  • [10] CARME B, 1983, ANN SOC BELG MED TR, V63, P333